C12orf57 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population from the HAP1 near-haploid cell line, offering disruption of the C12orf57 gene. This polyclonal mix of edited alleles provides a cost-effective, ready-to-use tool for functional genomics, bypassing the need for clonal isolation while representing diverse CRISPR-induced edits for early-stage investigation.
The HAP1 cell line is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia cell line, exhibiting fibroblast-like morphology and a predominantly haploid karyotype aside from a disomic chromosome 8. Widely used in genetic studies, HAP1 cells enable complete gene knockouts via single-allele targeting and are particularly suited for haploid screens to probe gene function, drug-gene interactions, and essentiality.
The C12orf57 gene encodes a protein of unknown function that is predicted to localize to mitochondria. Although its precise molecular role remains uncharacterized, existing evidence suggests involvement in mitochondrial metabolism, likely associated with oxidative phosphorylation and the mitochondrial ribosome. Representative pathway components include mitochondrial respiratory chain complexes I?CV and the mitochondrial translation machinery. Loss-of-function of C12orf57 is thought to impair mitochondrial bioenergetics, potentially leading to defects in cellular respiration and energy homeostasis. The absence of confirmed upstream regulators, downstream targets, or interacting factors reflects the current knowledge gap, positioning this knockout model as a valuable platform for discovery-oriented research.
In the HAP1 background, ablation of C12orf57 permits dissection of its contribution to mitochondrial functions in a simplified genetic context. The haploid nature of HAP1 cells ensures that gene disruption effectively eliminates protein expression without the complication of a second allele, thereby enhancing the penetrance of phenotypic effects. This model enables researchers to bypass the complexity of diploid systems and facilitates clear genotype-phenotype correlations. The knockout population can be used to assay fundamental mitochondrial processes, including respiratory chain activity, mitochondrial ribosome assembly, and apoptosis susceptibility, providing a tractable system to link C12orf57 to Temtamy syndrome-related pathologies such as intellectual disability and craniofacial dysmorphism.
This knockout product supports a wide range of applications, from basic functional genomics to disease modeling. It is suitable for western blotting and RT-qPCR to verify loss of expression, immunofluorescence to assess subcellular localization, and mitochondrial respiration assays to measure oxygen consumption. Cell proliferation and apoptosis assays enable characterization of growth defects and cell death pathways. Additionally, the cells can be employed in drug screening campaigns targeting mitochondrial dysfunction. Researchers focusing on Temtamy syndrome, mitochondrial biology, or cancer metabolism will find this model instrumental for hypothesis generation. For additional support, please contact Ascent Research.
